Marchetti, Monia; Barosi, Giovanni - In: PharmacoEconomics 22 (2004) 16, pp. 1029-1045
Anaemia develops in most patients undergoing cancer therapy and invariably induces fatigue, which is a major … determinant of QOL. Blood transfusions are reserved for patients with severe anaemia, since blood is a scarce resource and … provides a short-lived benefit. Epoetins are recombinant proteins capable of alleviating therapy-related anaemia in 40-60% of …